West-Ward sees shortages as 'major opportunity'

Citing stats from the FDA on growing drug shortages, Michael Raya of service provider West-Ward is taking action. "We see this as a major opportunity," he says in a statement. The Hikma Pharmaceuticals subsidiary recently acquired Baxter's multi-source injectables business, including a sterile injectable facility. Injectables are among the most common of drugs in short supply. Raya says he envisions West-Ward--with its operations versatility, solid compliance record and network of U.S. and European facilities--as "one of the leading global providers of contract dosage form development and manufacturing services." Release

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.